BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7200471)

  • 1. A study of antispermatozoal antibodies in leprosy.
    Gupta SC; Chhabra B; Mehrotra TN; Bajaj AK
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):43-6. PubMed ID: 7200471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antispermatozoal antibodies in leprosy with special reference to their morphological patterns.
    Gupta SC; Singh PA; Bajaj AK; Budhraja BK; Tripathi A
    Indian J Lepr; 1986; 58(2):196-201. PubMed ID: 3805791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic aspects of leprosy with special reference to the circulating antispermatozoal antibodies.
    Saha K; Gupta I
    Int J Lepr Other Mycobact Dis; 1977; 45(1):28-37. PubMed ID: 68938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL).
    Sharma VK; Saha K; Sehgal VN
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK; Jacobson RR; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
    Schwerer B; Meeker HC; Sersen G; Levis WR
    Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
    Sasiain MC; Ruibal Ares B; Baliña LM; Valdez R; Bachmann AE
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tr, T mu and B lymphocytes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1986; 58(4):601-8. PubMed ID: 2952738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol precipitates in serum during and after erythema nodosum leprosum--study of their composition and anticomplementary activity.
    Saha K; Chakrabarty AK; Sharma VK; Sehgal VN
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):44-8. PubMed ID: 6538557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in lepromatous leprosy.
    Ochieng NA; Bwire MS; Orege PA; Nyawalo JO; K'Omollo JW
    Afr J Health Sci; 1994 May; 1(2):79-83. PubMed ID: 12153365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes and complement hypercatabolism in patients with leprosy.
    Bjorvatn B; Barnetson RS; Kronvall G; Zubler RH; Lambert PH
    Clin Exp Immunol; 1976 Dec; 26(3):388-96. PubMed ID: 1009681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
    Jain VK; Verma KC; Aggarwal SS
    Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
    Beuria MK; Mohanty KK; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT; de Oliveira EB; Silva CL
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema nodosum leprosum: reactional leprosy.
    Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
    Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A; Hussain R
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defect in the generation of cytotoxic T cells in lepromatous leprosy.
    Stach JL; Strobel M; Fumoux F; Bach JF
    Clin Exp Immunol; 1982 Jun; 48(3):633-40. PubMed ID: 6214342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lymphocytotoxic activity in leprosy.
    Rasheed FN; Locniskar M; McCloskey DJ; Hasan RS; Chiang TJ; Rose P; de Soldenhoff R; Festenstein H; McAdam KP
    Clin Exp Immunol; 1989 Jun; 76(3):391-7. PubMed ID: 2752595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.